BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Anticancer prodrugs
,
Bleomycin
,
rs7903146
,
SNCA
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HLA
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Peripheral blood monocytes response to soluble MHC Class II
CD8+ naive or activated T cells from PBMCs of dengue or dengue hemorrhagic patients
Macrophages infected with Salmonella typhimurium or Listeria monocytogenes
T cells gene expression profiling of enriched CD4+CD25+HLADR+ and CD4+CD25-
CD4+ T cells with innate memory phenotype (IMP); effects of thymic or hematopoietic MHCII deficiency
Explore Curated Studies Results
Literature
Most Relevant Literature
The UFM1 Pathway Impacts HCMV US2-Mediated Degradation of HLA Class I.
HLA study in Bolivian Quechua Amerindians from Titikaka Lake Area.
Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Ha…
Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity:…
HLA Population Genetics in Solid Organ Transplantation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Relevance of Typing HLA-DR7-DQ2
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cance…
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumor…
HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ